<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03896841</url>
  </required_header>
  <id_info>
    <org_study_id>25801608</org_study_id>
    <nct_id>NCT03896841</nct_id>
  </id_info>
  <brief_title>Ocular Findings of Polycystic Ovary Syndrome</brief_title>
  <official_title>Ocular Surface Disease Test Results, Corneal Biomechanical Properties, and Structural Parameters in Patients With Polycystic Ovary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Medeniyet University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Medeniyet University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: This study aimed to compare the ocular surface disease test results, anterior
      segment parameters, and ocular response analyzer (ORA) findings of polycystic ovary syndrome
      (PCOS) patients with those of healthy reproductive age female controls.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 17, 2013</start_date>
  <completion_date type="Actual">March 30, 2018</completion_date>
  <primary_completion_date type="Actual">March 20, 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the anterior segment parameter results (Pentacam).</measure>
    <time_frame>1 year</time_frame>
    <description>measurement of the central corneal thickness.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of the corneal biomechanical parameter results (ocular response analyzer).</measure>
    <time_frame>1 year</time_frame>
    <description>measurement of the corneal hysteresis (CH).</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">38</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>PCOS</arm_group_label>
    <description>premenopausal patients with PCOS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control subjects</arm_group_label>
    <description>non-pregnant healthy control subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>Ocular Findings Observations</description>
    <arm_group_label>PCOS</arm_group_label>
    <arm_group_label>control subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This was a prospective, case-control study in which 23 premenopausal patients with PCOS
        diagnoses and 15 non-pregnant healthy control subjects were included.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  premenopausal with PCOS

        Exclusion Criteria:

          -  patients with external ocular disease other than dry eye complaints,

          -  use of topical drops that can affect the tear film layer,

          -  contact lens use histories,

          -  those who received hormone therapy for 6 months,

          -  those who have systemic medication or systemic disease that may affect the tear film
             layer and reproductive physiology,

          -  previous eye surgeries,

          -  smokers and alcohol users,

          -  those having diseases (Cushing's syndrome or androgen-secreting tumors) causing
             similar clinical findings.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 13, 2019</study_first_submitted>
  <study_first_submitted_qc>March 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2019</study_first_posted>
  <last_update_submitted>March 28, 2019</last_update_submitted>
  <last_update_submitted_qc>March 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul Medeniyet University</investigator_affiliation>
    <investigator_full_name>Mustafa Hepokur</investigator_full_name>
    <investigator_title>Medical Doctor, Clinical Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

